Nabriva Therapeutics has announced the appointment of Jennifer Schranz, M.D., as chief medical officer.   “Jennifer has broad expertise in infectious diseases and internal medicine with extensive experience in both clinical development and medical affairs for small molecules and biologics,” said Dr. Colin Broom, chief executive officer of Nabriva Therapeutics. “She brings a track record of successfully navigating the regulatory submission and approval process, as well as leading medical ...